Lead Plaintiff Deadline is Approaching - Act Now

Cassava Sciences Inc® Class Action

Crocker v. Cassava Sciences, Inc. et al.

Cassava Sciences Inc

NASDAQ: NYSE: Sava

Class Period : 02/07/2024 - 11/24/2024

Lead Plaintiff Motion Deadline: 2/10/2025

Alleged Misstatements and Omissions
The Cassava class action lawsuit claims that the company misled investors by making false and misleading statements about its leading drug candidate, simufilam. Specifically, the company expressed evident confidence in simufilam’s ability to treat Alzheimer's disease despite allegedly lacking sufficient evidence to support these claims.

These statements painted an overly optimistic picture of simufilam’s effectiveness, leading investors to believe in its success.

Effects on Stock Prices
On November 25, 2024, Cassava revealed disappointing topline results from its Phase 3 "ReThink-ALZ" study. The results showed that simufilam failed to meet all pre-specified primary, secondary, and exploratory endpoints, performing no better than a placebo.

As a result:

  • Share Price Plunge: Cassava's stock price plummeted from $26.48 per share on November 22, 2024, to $4.30 per share on November 25, 2024—a dramatic decline of approximately 83.76%.
  • Investor Losses: Shareholders suffered severe financial losses as the stock value collapsed.

Legal Rights for Affected Shareholders
Shareholders who purchased Cassava stock before November 25, 2024, may have legal grounds to recover their losses. The lawsuit alleges violations of securities laws, claiming that Cassava misled investors about the prospects of its drug candidate and withheld critical information about its effectiveness.

By joining this class action, you can:

  • Seek financial compensation for losses tied to Cassava stock.
  • Hold the company accountable for its alleged misrepresentations.
  • Advocate for more transparency and fairness in investor communications.

Take Action Today
Protect your legal rights by acting promptly. Contact experienced securities fraud attorneys to explore your options if you purchased Cassava stock and suffered losses. Filing your claim before legal deadlines ensures you don't miss your chance to recover damages.

By joining the Cassava class action, you join other affected shareholders in demanding accountability and pursuing fair compensation for your losses. Don't wait—time is critical. Take action today.

iStock-1170678985

DiCello Levitt Fights to Protect Shareholder Rights  

At DiCello Levitt, we are dedicated to representing shareholders harmed by corporate misconduct. Our experienced legal team is committed to holding companies accountable when they mislead investors and cause financial losses. With a proven track record in securities litigation, we understand what it takes to build a strong case and fight for maximum compensation.  

If you've suffered losses due to Cassava Sciences, Inc.'s alleged misstatements, we're here to help. Contact us today for a free, confidential case evaluation. Learn about your legal options and determine the potential value of your claim. Don't wait—let us advocate for your rights and help you seek the justice you deserve.

All victims affected by Cassava Sciences, Inc.®'s alleged deceptive practices and failure to meet basic compliance standards should receive justice and potential compensation, beginning with a free, private case review with our experienced legal team.

The Importance of Joining a Class Action

Class action lawsuits can provide an efficient mechanism to compensate injured victims, hold wrongdoers accountable, or affect how a company or an industry operates.  Class actions allow injured parties to come together and take on larger adversaries.  By leveraging the power of a group class members the class can match the resources of a corporate defendant and put the parties on equal footing.

If you have been adversely affected by corporate misconduct, you may join DiCello Levitt’s class action lawsuit and help hold the wrongdoers responsible for their alleged misconduct, potentially recover your financial losses, and contribute to enforcing higher ethical, governance, and compliance standards.  Your participation can make a difference.

To learn more about how to join the lawsuit and your potential eligibility, please contact DiCello Levitt.  DiCello Levitt is committed to representing the interests of all affected parties and pursuing justice in this significant case.

Find Out if You may be a Member
of the Class

Cassava Sciences Inc® Class Action

Crocker v. Cassava Sciences, Inc. et al.

Cassava Sciences Inc

NASDAQ: NYSE: Sava

Class Period : 02/07/2024 - 11/24/2024

Lead Plaintiff Motion Deadline: 2/10/2025

Alleged Misstatements and Omissions
The Cassava class action lawsuit claims that the company misled investors by making false and misleading statements about its leading drug candidate, simufilam. Specifically, the company expressed evident confidence in simufilam’s ability to treat Alzheimer's disease despite allegedly lacking sufficient evidence to support these claims.

These statements painted an overly optimistic picture of simufilam’s effectiveness, leading investors to believe in its success.

Effects on Stock Prices
On November 25, 2024, Cassava revealed disappointing topline results from its Phase 3 "ReThink-ALZ" study. The results showed that simufilam failed to meet all pre-specified primary, secondary, and exploratory endpoints, performing no better than a placebo.

As a result:

  • Share Price Plunge: Cassava's stock price plummeted from $26.48 per share on November 22, 2024, to $4.30 per share on November 25, 2024—a dramatic decline of approximately 83.76%.
  • Investor Losses: Shareholders suffered severe financial losses as the stock value collapsed.

Legal Rights for Affected Shareholders
Shareholders who purchased Cassava stock before November 25, 2024, may have legal grounds to recover their losses. The lawsuit alleges violations of securities laws, claiming that Cassava misled investors about the prospects of its drug candidate and withheld critical information about its effectiveness.

By joining this class action, you can:

  • Seek financial compensation for losses tied to Cassava stock.
  • Hold the company accountable for its alleged misrepresentations.
  • Advocate for more transparency and fairness in investor communications.

Take Action Today
Protect your legal rights by acting promptly. Contact experienced securities fraud attorneys to explore your options if you purchased Cassava stock and suffered losses. Filing your claim before legal deadlines ensures you don't miss your chance to recover damages.

By joining the Cassava class action, you join other affected shareholders in demanding accountability and pursuing fair compensation for your losses. Don't wait—time is critical. Take action today.

iStock-1170678985

DiCello Levitt Fights to Protect Shareholder Rights  

At DiCello Levitt, we are dedicated to representing shareholders harmed by corporate misconduct. Our experienced legal team is committed to holding companies accountable when they mislead investors and cause financial losses. With a proven track record in securities litigation, we understand what it takes to build a strong case and fight for maximum compensation.  

If you've suffered losses due to Cassava Sciences, Inc.'s alleged misstatements, we're here to help. Contact us today for a free, confidential case evaluation. Learn about your legal options and determine the potential value of your claim. Don't wait—let us advocate for your rights and help you seek the justice you deserve.

All victims affected by Cassava Sciences, Inc.®'s alleged deceptive practices and failure to meet basic compliance standards should receive justice and potential compensation, beginning with a free, private case review with our experienced legal team.

The Importance of Joining a Class Action

Class action lawsuits can provide an efficient mechanism to compensate injured victims, hold wrongdoers accountable, or affect how a company or an industry operates.  Class actions allow injured parties to come together and take on larger adversaries.  By leveraging the power of a group class members the class can match the resources of a corporate defendant and put the parties on equal footing.

If you have been adversely affected by corporate misconduct, you may join DiCello Levitt’s class action lawsuit and help hold the wrongdoers responsible for their alleged misconduct, potentially recover your financial losses, and contribute to enforcing higher ethical, governance, and compliance standards.  Your participation can make a difference.

To learn more about how to join the lawsuit and your potential eligibility, please contact DiCello Levitt.  DiCello Levitt is committed to representing the interests of all affected parties and pursuing justice in this significant case.

100% Free & Secure Case Evaluations

Answer a few basic questions to get started

We'll ask specific questions to understand the situation, damage risk, and other vital information to help determine the next steps.

Receive a confidential evaluation

A qualified legal team led by a Financial Products Litigation attorney will consider the facts of your case.

Cassava Sciences, Inc.®'s Investors may have grounds to pursue legal action and financial recovery of damages.

This website offers general information only and is not legal or investment advice. This advertisement is not associated with any government agency.

www.stockfraudclaim.com is the property of Shield Legal LLC. 5170 Badura Ave Las Vegas, NV 89118

Participating law firm: DiCello Levitt LLP, 10 North Dearborn Street Sixth Floor Chicago, IL 60602. For additional terms, disclaimers, and conditions, please visit https://dicellolevitt.com/privacy-policy/

This website is not part of the Facebook website or Facebook, Inc., and it is NOT endorsed by Facebook in any way. FACEBOOK is a trademark of Facebook, Inc.

ATTORNEY ADVERTISING. This Website does not provide investment, legal, or medical advice. Every case is evaluated on its facts and circumstances. Valuation depends on facts, injuries, jurisdiction, venue, witnesses, parties, and testimony, among other factors. No representation is made that the quality of legal services to be performed is greater than the quality of legal services performed by other lawyers. Stock Fraud Claim does not itself provide legal services. Cases will be referred to third-party attorneys and law firms.  Court costs and case expenses may be the responsibility of the client. Not available in all states. This advertisement is not intended as a testimonial, endorsement, or dramatization and does not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter, either expressed or implied. Anyone considering a lawyer should independently investigate the lawyer's credentials and ability, and not rely upon advertisements or self-proclaimed expertise. Only persons age 18 or older have permission to access our Service. Our Service does not address anyone under 13 ("Children").

NO ATTORNEY-CLIENT RELATIONSHIP. Use of this website, including sending or receiving information through it, does not establish an attorney-client relationship, nor is any non-passworded information considered privileged or confidential. No class has been certified.  Until a case is filed and a class is certified, you are not represented by counsel unless you retain one.  You may select counsel of your choice.  An attorney-client relationship with DiCello Levitt is established only by an express written agreement signed by DiCello Levitt to represent you.

Attorney Advertising.  Prior results do not guarantee a similar outcome.

Privacy Policy | Terms and Conditions | CCPA Privacy Notice | Do Not Sell My Info

©2024 Stock Fraud Claim. All Rights Reserved